Biliary innate immunity in the pathogenesis of biliary diseases

Inflammation and Allergy - Drug Targets

Volumn 9, Issue 2, 2010, Pages 83-90

  Harada, Kenichi ^a   Nakanuma, Yasuni ^a  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

Author keywords

Biliary atresia; Biliary epithelial cells; Cholangiopathy; Innate immunity; Primary biliary cirrhosis; Tolerance; Tolllike receptors

Indexed keywords

DOUBLE STRANDED RNA; INTERLEUKIN 17; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RETINOIC ACID INDUCIBLE PROTEIN I; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 3; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

APOPTOSIS; ARTICLE; BILE DUCT ATRESIA; BILE DUCT DISEASE; BILIARY TRACT DISEASE; CD4+ T LYMPHOCYTE; CHRONIC INFLAMMATION; EPITHELIAL MESENCHYMAL TRANSITION; INNATE IMMUNITY; PATHOGENESIS; PRIMARY BILIARY CIRRHOSIS; TH17 CELL; ANIMAL; BILE; BILE DUCT; BILIARY CIRRHOSIS; HEPATOBILIARY SYSTEM; HUMAN; IMMUNOLOGY; METABOLISM; PATHOLOGY;

ANIMALS; BILE; BILE DUCT DISEASES; BILE DUCTS; BILIARY ATRESIA; BILIARY TRACT; HUMANS; IMMUNITY, INNATE; LIVER CIRRHOSIS, BILIARY; TOLL-LIKE RECEPTORS;

EID: 77953749477     PISSN: 18715281     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152810791292809     Document Type: Article

References (69)

1. Abreu, M.T.; Vora, P.; Faure, E.; Thomas, L.S.; Arnold, E.T.; Arditi, M. Decreased expression of Toll-like receptor-4 and MD-2 correlates with intestinal epithelial cell protection against dysregulated proinflammatory gene expression in response to bacterial lipopolysaccharide. J. Immunol., 2001, 167(3), 1609-1616.
2. Sheen-Chen, S.; Chen, W.; Eng, H.; Sheen, C.; Chou, F.; Cheng, Y.; Lee, T. Bacteriology and antimicrobial choice in hepatolithiasis. Am. J. Infect. Control, 2000, 28(4), 298-301.
3. Hiramatsu, K.; Harada, K.; Tsuneyama, K.; Sasaki, M.; Fujita, S.; Hashimoto, T.; Kaneko, S.; Kobayashi, K.; Nakanuma, Y. Amplification and sequence analysis of partial bacterial 16S ribosomal RNA gene in gallbladder bile from patients with primary biliary cirrhosis. J. Hepatol., 2000, 33(1), 9-18.
4. Sasatomi, K.; Noguchi, K.; Sakisaka, S.; Sata, M.; Tanikawa, K. Abnormal accumulation of endotoxin in biliary epithelial cells in primary biliary cirrhosis and primary sclerosing cholangitis. J. Hepatol., 1998, 29(3), 409-416.
5. Harada, K.; Ozaki, S.; Kono, N.; Tsuneyama, K.; Katayanagi, K.; Hiramatsu, K.; Nakanuma, Y. Frequent molecular identification of Campylobacter but not Helicobacter genus in bile and biliary epithelium in hepatolithiasis. J. Pathol., 2001, 193(2), 218-223.
6. Harada, K.; Tsuneyama, K.; Sudo, Y.; Masuda, S.; Nakanuma, Y. Molecular identification of bacterial 16S ribosomal RNA gene in liver tissue of primary biliary cirrhosis: is Propionibacterium acnes involved in granuloma formation? Hepatology, 2001, 33(3), 530-536.
7. Nilsson, H.O.; Taneera, J.; Castedal, M.; Glatz, E.; Olsson, R.; Wadstrom, T. Identification of Helicobacter pylori and other Helicobacter species by PCR, hybridization, and partial DNA sequencing in human liver samples from patients with primary sclerosing cholangitis or primary biliary cirrhosis. J. Clin. Microbiol., 2000, 38(3), 1072-1076.
8. Nakanuma, Y.; Yamaguchi, K.; Ohta, G.; Terada, T. Pathologic features of hepatolithiasis in Japan. Hum. Pathol., 1988, 19(10), 1181-1186.
9. Sung, J.Y.; Costerton, J.W.; Shaffer, E.A. Defense system in the biliary tract against bacterial infection. Dig. Dis. Sci., 1992, 37(5), 689-696.
10. Saito, K.; Nakanuma, Y. Lactoferrin and lysozyme in the intrahepatic bile duct of normal livers and hepatolithiasis. An immunohistochemical study. J. Hepatol., 1992, 15(1-2), 147-153.
11. Sugiura, H.; Nakanuma, Y. Secretory component and immunoglobulins in the intrahepatic biliary tree and peribiliary gland in normal livers and hepatolithiasis. Gastroenterol. Jpn., 1989, 24(3), 308-314.
12. Harada, K.; Ohba, K.; Ozaki, S.; Isse, K.; Hirayama, T.; Wada, A.; Nakanuma, Y. Peptide antibiotic human beta-defensin-1 and -2 contribute to antimicrobial defense of the intrahepatic biliary tree. Hepatology, 2004, 40(4), 925-932.
13. Nakanuma, Y.; Hoso, M.; Sanzen, T.; Sasaki, M. Microstructure and development of the normal and pathologic biliary tract in humans, including blood supply. Microsc. Res. Tech., 1997, 38(6), 552-570.
14. Lefkowitch, J.H. Bile ductular cholestasis: an ominous histopathologic sign related to sepsis and "cholangitis lenta". Hum. Pathol., 1982, 13(1), 19-24.
15. Isse, K.; Harada, K.; Nakanuma, Y. IL-8 expression by biliary epithelial cells is associated with neutrophilic infiltration and reactive bile ductules. Liver Int., 2007, 27(5), 672-680.
16. Anderson, K.V. Toll signaling pathways in the innate immune response. Curr. Opin. Immunol., 2000, 12(1), 13-19.
17. Takeda, K.; Akira, S. Toll-like receptors in innate immunity. Int. Immunol., 2005, 17(1), 1-14.
18. Harada, K.; Isse, K.; Nakanuma, Y. Interferon gamma accelerates NF-kappaB activation of biliary epithelial cells induced by Tolllike receptor and ligand interaction. J. Clin. Pathol., 2006, 59(2), 184-190.
19. Harada, K.; Ohira, S.; Isse, K.; Ozaki, S.; Zen, Y.; Sato, Y.; Nakanuma, Y. Lipopolysaccharide activates nuclear factor-kappaB through toll-like receptors and related molecules in cultured biliary epithelial cells. Lab Invest., 2003, 83(11), 1657-1667.
20. Yokoyama, T.; Komori, A.; Nakamura, M.; Takii, Y.; Kamihira, T.; Shimoda, S.; Mori, T.; Fujiwara, S.; Koyabu, M.; Taniguchi, K.; Fujioka, H.; Migita, K.; Yatsuhashi, H.; Ishibashi, H. Human intrahepatic biliary epithelial cells function in innate immunity by producing IL-6 and IL-8 via the TLR4-NF-kappaB and -MAPK signaling pathways. Liver Int., 2006, 26(4), 467-476.
21. Wang, A.P.; Migita, K.; Ito, M.; Takii, Y.; Daikoku, M.; Yokoyama, T.; Komori, A.; Nakamura, M.; Yatsuhashi, H.; Ishibashi, H. Hepatic expression of toll-like receptor 4 in primary biliary cirrhosis. J. Autoimmun., 2005, 25(1), 85-91.
22. Takii, Y.; Nakamura, M.; Ito, M.; Yokoyama, T.; Komori, A.; Shimizu-Yoshida, Y.; Nakao, R.; Kusumoto, K.; Nagaoka, S.; Yano, K.; Abiru, S.; Ueki, T.; Matsumoto, T.; Daikoku, M.; Taniguchi, K.; Fujioka, H.; Migita, K.; Yatsuhashi, H.; Nakashima, M.; Harada, M.; Ishibashi, H. Enhanced expression of type I interferon and toll-like receptor-3 in primary biliary cirrhosis. Lab Invest., 2005, 85(7), 908-920.
23. Nakamura, M.; Funami, K.; Komori, A.; Yokoyama, T.; Aiba, Y.; Araki, A.; Takii, Y.; Ito, M.; Matsuyama, M.; Koyabu, M.; Migita, K.; Taniguchi, K.; Fujioka, H.; Yatsuhashi, H.; Matsumoto, M.; Ishibashi, H.; Seya, T. Increased expression of Toll-like receptor 3 in intrahepatic biliary epithelial cells at sites of ductular reaction in diseased livers. Hepatol. Int., 2008, 2(2), 222-230.
24. Harada, K.; Sato, Y.; Itatsu, K.; Isse, K.; Ikeda, H.; Yasoshima, M.; Zen, Y.; Matsui, A.; Nakanuma, Y. Innate immune response to double-stranded RNA in biliary epithelial cells is associated with the pathogenesis of biliary atresia. Hepatology, 2007, 46(4), 1146-1154.
25. Harada, K.; Shimoda, S.; Sato, Y.; Isse, K.; Ikeda, H.; Nakanuma, Y. Periductal interleukin-17 production in association with biliary innate immunity contributes to the pathogenesis of cholangiopathy in primary biliary cirrhosis. Clin. Exp. Immunol., 2009, 157261-270.
26. Isse, K.; Harada, K.; Zen, Y.; Kamihira, T.; Shimoda, S.; Harada, M.; Nakanuma, Y. Fractalkine and CX3CR1 are involved in the recruitment of intraepithelial lymphocytes of intrahepatic bile ducts. Hepatology, 2005, 41(3), 506-516.
27. Sawada, S.; Harada, K.; Isse, K.; Sato, Y.; Sasaki, M.; Kaizaki, Y.; Nakanuma, Y. Involvement of Escherichia coli in pathogenesis of xanthogranulomatous cholecystitis with scavenger receptor class A and CXCL16-CXCR6 interaction. Pathol. Int., 2007, 57(10), 652-663.
28. Shimoda, S.; Harada, K.; Niiro, H.; Yoshizumi, T.; Soejima, Y.; Taketomi, A.; Maehara, Y.; Tsuneyama, K.; Nakamura, M.; Komori, A.; Migita, K.; Nakanuma, Y.; Ishibashi, H.; Selmi, C.; Gershwin, ME. Biliary epithelial cells and primary biliary cirrhosis: the role of liver-infiltrating mononuclear cells. Hepatology, 2008, 47(3), 958-965.
29. Abreu, M.T.; Arnold, E.T.; Thomas, L.S.; Gonsky, R.; Zhou, Y.; Hu, B.; Arditi, M. TLR4 and MD-2 expression is regulated by immune-mediated signals in human intestinal epithelial cells. J. Biol. Chem., 2002, 277(23), 20431-20437.
30. Matsumura, T.; Ito, A.; Takii, T.; Hayashi, H.; Onozaki, K. Endotoxin and cytokine regulation of toll-like receptor (TLR) 2 and TLR4 gene expression in murine liver and hepatocytes. J. Interferon Cytokine Res., 2000, 20(10), 915-921.
31. Harada, K.; Van de Water, J.; Leung, P.S.; Coppel, R.L.; Ansari, A.; Nakanuma, Y.; Gershwin, ME. In situ nucleic acid hybridization of cytokines in primary biliary cirrhosis: predominance of the Th1 subset. Hepatology, 1997, 25(4), 791-796.
32. Chen, X.M.; O'Hara, S.P.; Nelson, J.B.; Splinter, P.L.; Small, A.J.; Tietz, P.S.; Limper, A.H.; LaRusso, N.F. Multiple TLRs are expressed in human cholangiocytes and mediate host epithelial defense responses to Cryptosporidium parvum via activation of NF-kappaB. J. Immunol., 2005, 175(11), 7447-7456.
33. Chen, X.M.; Splinter, P.L.; O'Hara, S.P.; LaRusso, N.F. A cellular micro-RNA, let-7i, regulates Toll-like receptor 4 expression and contributes to cholangiocyte immune responses against Cryptosporidium parvum infection. J. Biol. Chem., 2007, 282(39), 28929-28938.
34. Kobayashi, K.; Hernandez, L.D.; Galan, J.E.; Janeway, C.A, Jr.; Medzhitov, R.; Flavell, R.A. IRAK-M is a negative regulator of Toll-like receptor signaling. Cell, 2002, 110(2), 191-202.
35. Otte, J.M.; Cario, E.; Podolsky, D.K. Mechanisms of cross hyporesponsiveness to Toll-like receptor bacterial ligands in intestinal epithelial cells. Gastroenterology, 2004, 126(4), 1054-1070.
36. Harada, K.; Isse, K.; Sato, Y.; Ozaki, S.; Nakanuma, Y. Endotoxin tolerance in human intrahepatic biliary epithelial cells is induced by upregulation of IRAK-M. Liver Int., 2006, 26(8), 935-942.
37. Harada, K.; Sato, Y.; Isse, K.; Ikeda, H.; Nakanuma, Y. Induction of innate immune response and absence of subsequent tolerance to dsRNA in biliary epithelial cells relate to the pathogenesis of biliary atresia. Liver Int., 2008, 28(5), 614-621.
38. Kliewer, S.A.; Lenhard, J.M.; Willson, T.M.; Patel, I.; Morris, D.C.; Lehmann, J.M. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation. Cell, 1995, 83(5), 813-819.
39. Dubuquoy, L.; Jansson, E.A.; Deeb, S.; Rakotobe, S.; Karoui, M.; Colombel, J.F.; Auwerx, J.; Pettersson, S.; Desreumaux, P. Impaired expression of peroxisome proliferator-activated receptor gamma in ulcerative colitis. Gastroenterology, 2003, 124(5), 1265-1276.
40. Waite, K.J.; Floyd, Z.E.; Arbour-Reily, P.; Stephens, J.M. Interferon-gamma-induced regulation of peroxisome proliferatoractivated receptor gamma and STATs in adipocytes. J. Biol. Chem., 2001, 276(10), 7062-7068.
41. Harada, K.; Isse, K.; Kamihira, T.; Shimoda, S.; Nakanuma, Y. Th1 cytokine-induced downregulation of PPARgamma in human biliary cells relates to cholangitis in primary biliary cirrhosis. Hepatology, 2005, 41(6), 1329-1338.
42. Nakanuma, Y.; Ohta, G. Histometric and serial section observations of the intrahepatic bile ducts in primary biliary cirrhosis. Gastroenterology, 1979, 76(6), 1326-1332.
43. Parikh-Patel, A.; Gold, E.B.; Worman, H.; Krivy, K.E.; Gershwin, M.E. Risk factors for primary biliary cirrhosis in a cohort of patients from the united states. Hepatology, 2001, 33(1), 16-21.
44. Shimoda, S.; Nakamura, M.; Ishibashi, H.; Hayashida, K.; Niho, Y. HLA DRB4 0101-restricted immunodominant T cell autoepitope of pyruvate dehydrogenase complex in primary biliary cirrhosis: evidence of molecular mimicry in human autoimmune diseases. J. Exp. Med., 1995, 181(5), 1835-1845.
45. Selmi, C.; Balkwill, D.L.; Invernizzi, P.; Ansari, A.A.; Coppel, R.L.; Podda, M.; Leung, P.S.; Kenny, T.P.; Van De Water, J.; Nantz, M.H.; Kurth, M.J.; Gershwin, ME. Patients with primary biliary cirrhosis react against a ubiquitous xenobiotic-metabolizing bacterium. Hepatology, 2003, 38(5), 1250-1257.
46. Yasoshima, M.; Kono, N.; Sugawara, H.; Katayanagi, K.; Harada, K.; Nakanuma, Y. Increased expression of interleukin-6 and tumor necrosis factor-alpha in pathologic biliary epithelial cells: in situ and culture study. Lab Invest., 1998, 78(1), 89-100.
47. Harada, K.; Ozaki, S.; Gershwin, ME.; Nakanuma, Y. Enhanced apoptosis relates to bile duct loss in primary biliary cirrhosis. Hepatology, 1997, 26(6), 1399-1405.
48. Odin, J.A.; Huebert, R.C.; Casciola-Rosen, L.; LaRusso, N.F.; Rosen, A. Bcl-2-dependent oxidation of pyruvate dehydrogenase- E2, a primary biliary cirrhosis autoantigen, during apoptosis. J. Clin. Invest., 2001, 108(2), 223-232.
49. Koga, H.; Sakisaka, S.; Ohishi, M.; Sata, M.; Tanikawa, K. Nuclear DNA fragmentation and expression of Bcl-2 in primary biliary cirrhosis. Hepatology, 1997, 25(5), 1077-1084.
50. Kuroki, T.; Seki, S.; Kawakita, N.; Nakatani, K.; Hisa, T.; Kitada, T.; Sakaguchi, H. Expression of antigens related to apoptosis and cell proliferation in chronic nonsuppurative destructive cholangitis in primary biliary cirrhosis. Virchows Arch, 1996, 429(2-3), 119-129.
51. Cario, E.; Podolsky, DK. Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect. Immun., 2000, 68(12), 7010-7017.
52. Mangan, P.R.; Harrington, L.E.; O'Quinn, D.B.; Helms, W.S.; Bullard, D.C.; Elson, C.O.; Hatton, R.D.; Wahl, S.M.; Schoeb, T.R.; Weaver, C.T. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature, 2006, 441(7090), 231-234.
53. Acosta-Rodriguez, E.V.; Napolitani, G.; Lanzavecchia, A.; Sallusto, F. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17- producing human T helper cells. Nat. Immunol., 2007, 8(9), 942-949.
54. Lan, R.Y.; Salunga, T.L.; Tsuneyama, K.; Lian, Z.X.; Yang, G.X.; Hsu, W.; Moritoki, Y.; Ansari, A.A.; Kemper, C.; Price, J.; Atkinson, J.P.; Coppel, R.L.; Eric Gershwin, M. Hepatic IL-17 responses in human and murine primary biliary cirrhosis. J. Autoimmun., 2009, 32(1), 43-51.
55. Morecki, R.; Glaser, J.H.; Cho, S.; Balistreri, W.F.; Horwitz, M.S. Biliary atresia and reovirus type 3 infection. N. Engl. J. Med., 1982, 307(8), 481-484.
56. Tyler, K.L.; Sokol, R.J.; Oberhaus, S.M.; Le, M.; Karrer, F.M.; Narkewicz, M.R.; Tyson, R.W.; Murphy, J.R.; Low, R.; Brown, W.R. Detection of reovirus RNA in hepatobiliary tissues from patients with extrahepatic biliary atresia and choledochal cysts. Hepatology, 1998, 27(6), 1475-1482.
57. Riepenhoff-Talty, M.; Schaekel, K.; Clark, H.F.; Mueller, W.; Uhnoo, I.; Rossi, T.; Fisher, J.; Ogra, P.L. Group A rotaviruses produce extrahepatic biliary obstruction in orally inoculated newborn mice. Pediatr. Res., 1993, 33(4 Pt 1), 394-399.
58. Szavay, P.O.; Leonhardt, J.; Czech-Schmidt, G.; Petersen, C. The role of reovirus type 3 infection in an established murine model for biliary atresia. Eur. J. Pediatr. Surg., 2002, 12(4), 248-250.
59. Funaki, N.; Sasano, H.; Shizawa, S.; Nio, M.; Iwami, D.; Ohi, R.; Nagura, H. Apoptosis and cell proliferation in biliary atresia. J. Pathol., 1998, 186(4), 429-433.
60. Sasaki, H.; Nio, M.; Iwami, D.; Funaki, N.; Sano, N.; Ohi, R.; Sasano, H. E-cadherin, alpha-catenin and beta-catenin in biliary atresia: correlation with apoptosis and cell cycle. Pathol. Int., 2001, 51(12), 923-932.
61. Harada, K.; Iwata, M.; Kono, N.; Koda, W.; Shimonishi, T.; Nakanuma, Y. Distribution of apoptotic cells and expression of apoptosis-related proteins along the intrahepatic biliary tree in normal and non-biliary diseased liver. Histopathology, 2000, 37(4), 347-354.
62. Nakanuma, Y.; Kono, N. Expression of vimentin in proliferating and damaged bile ductules and interlobular bile ducts in nonneoplastic hepatobiliary diseases. Mod. Pathol., 1992, 5(5), 550-554.
63. Rygiel, K.A.; Robertson, H.; Marshall, H.L.; Pekalski, M.; Zhao, L.; Booth, T.A.; Jones, DE.; Burt, AD.; Kirby, JA. Epithelialmesenchymal transition contributes to portal tract fibrogenesis during human chronic liver disease. Lab Invest., 2008, 88(2), 112-123.
64. Sato, Y.; Harada, K.; Ozaki, S.; Furubo, S.; Kizawa, K.; Sanzen, T.; Yasoshima, M.; Ikeda, H.; Sasaki, M.; Nakanuma, Y. Cholangiocytes with mesenchymal features contribute to progressive hepatic fibrosis of the polycystic kidney rat. Am. J. Pathol., 2007, 171(6), 1859-1871.
65. Diaz, R.; Kim, J.W.; Hui, J.J.; Li, Z.; Swain, G.P.; Fong, K.S.; Csiszar, K.; Russo, P.A.; Rand, E.B.; Furth, E.E.; Wells, R.G. Evidence for the epithelial to mesenchymal transition in biliary atresia fibrosis. Hum. Pathol., 2008, 39(1), 102-115.
66. Harada, K.; Sato, Y.; Ikeda, H.; Isse, K.; Ozaki, S.; Enomae, M.; Ohama, K.; Katayanagi, K.; Kurumaya, H.; Matsui, A.; Nakanuma, Y. Epithelial-mesenchymal transition induced by biliary innate immunity contributes to the sclerosing cholangiopathy of biliary atresia. J. Pathol., 2009, 217(5), 654-664.
67. Seki, E.; De Minicis, S.; Osterreicher, C.H.; Kluwe, J.; Osawa, Y.; Brenner, D.A.; Schwabe, R.F. TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat. Med., 2007, 13(11), 1324-1332.
68. Strutz, F.; Zeisberg, M.; Ziyadeh, F.N.; Yang, C.Q.; Kalluri, R.; Muller, G.A.; Neilson, E.G. Role of basic fibroblast growth factor-2 in epithelial-mesenchymal transformation. Kidney Int., 2002, 61(5), 1714-1728.
69. Valdes, F.; Alvarez, A.M.; Locascio, A.; Vega, S.; Herrera, B.; Fernandez, M.; Benito, M.; Nieto, M.A.; Fabregat, I. The epithelial mesenchymal transition confers resistance to the apoptotic effects of transforming growth factor Beta in fetal rat hepatocytes. Mol. Cancer Res., 2002, 1(1), 68-78.